Clinical Trials Browser

Phase 1/2 × montanide ISA 51 × Breast × Clear all

NCT00678509 2009-12-29

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer

Phase 1/2 Terminated

Breast Neoplasms